Bioretec’s products are very good, and there seems to be a continuous active approach to their development work. Marketing is understandably quite different from that of a weight loss drug or a cancer drug, which, if successful, are quickly absorbed into the market. On the other hand, once these products gain a foothold in surgery, I believe the market will be stable and grow sustainably. In my opinion, the strategy and goals are now realistic, and what could be better than if they can be exceeded. I believe that a new foundation is now being built, and they don’t want to cause new disappointments for investors. Some larger cooperation or acquisition is also reasonably likely. The obvious need for financing understandably creates uncertainty. I will definitely keep my position.
6 Likes